Learn more

ENGENEIC MOLECULAR DELIVERY PTY LTD

Overview
  • Total Patents
    162
  • GoodIP Patent Rank
    26,275
  • Filing trend
    ⇩ 84.0%
About

ENGENEIC MOLECULAR DELIVERY PTY LTD has a total of 162 patent applications. It decreased the IP activity by 84.0%. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are LIGOCYTE PHARMACEUTICALS INC, STAIDSON BEIJING BIOPHARMACEUTICALS CO LTD and WEINER DAVID B.

Patent filings per year

Chart showing ENGENEIC MOLECULAR DELIVERY PTY LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Macdiarmid Jennifer 151
#2 Brahmbhatt Himanshu 146
#3 Hulf Toby 20
#4 Jennifer Macdiarmid 7
#5 Brahmbatt Himanshu 6
#6 Himanshu Brahmbhatt 6
#7 Toby Hulf 1

Latest patents

Publication Filing date Title
WO2020222161A1 Compositions comprising bacterially derived intact minicells for theranostic applications
WO2020141495A1 Encapsulated glycolipid antigens for treatment of neoplastic diseases
SG11202100507PA Compositions comprising bacterially derived minicells and methods of using the same
EP3522935A1 Bacterial minicells for delivering nucleic acid adjuvants and methods of using the same
TW201628606A Enhanced loading of intact, bacterially derived vesicles with small molecule compounds
AU2015201118A1 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
US2015098897A1 Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma
AU2013203202A1 Delivering functional nucleic acids to mammalian cells via bacterially derived intact minicells
NZ709680A Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
AU2012261512A1 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
EP2865755A2 Bacterially derived, intact minicells encompassing regulatory RNA
EP2712618A1 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
CA2803995A1 Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells
CN102921019A Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells
CA2788707A1 Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
HK1064122A1 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo
US2004265994A1 Pharmaceutically compatible method for purifying intact bacterial minicells
MXPA04003493A Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo.